Home
#Global Trends
#Local Dynamics
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Eikon Therapeutics secures $381M in IPO amid biotech market resurgence

05/02/2026 Published by vivi

On February 4, 2026, California-based Eikon Therapeutics successfully raised $381 million in its initial public offering (IPO), marking the third... Read more

Tags: #Global Trends

AbbVie hits record $61.1B in sales as Skyrizi and Rinvoq eclipse Humira erosion

05/02/2026 Published by vivi

Despite facing nearly $16 billion in U.S. revenue erosion for its long-time blockbuster Humira, AbbVie reported a record-breaking $61.1 billion... Read more

Category: Uncategorized

Tags: #Global Trends

Resolution proposed to guide implementation of food safety regulations

05/02/2026 Published by vivi

During the Government press conference on February 4, Ministry of Health officials addressed current obstacles in the state inspection of... Read more

Category: Uncategorized

Tags: #Local Dynamics

Health authorities order stable medicine supply and pricing for Lunar New Year 2026

05/02/2026 Published by vivi

The Drug Administration of Vietnam (Ministry of Health) has issued an urgent directive to ensure that medicine remains accessible and... Read more

Category: Uncategorized

Tags: #Local Dynamics

Proposed 6-tier professional allowance framework for healthcare workers starting 2026

05/02/2026 Published by vivi

The Ministry of Health is currently seeking public feedback on a draft Decree aimed at restructuring professional allowance regimes for... Read more

Category: Uncategorized

Tags: #Local Dynamics

University Medical Center HCMC and Medtronic renew strategic partnership for the 5th time

05/02/2026 Published by vivi

On February 5, 2026, the University Medical Center Ho Chi Minh City (UMC) and Medtronic Vietnam signed their fifth Memorandum... Read more

Category: Uncategorized

Tags: #Local Dynamics

AGC Biologics Seattle facility receives Anvisa GMP certification from Brazil

04/02/2026 Published by vivi

On February 3, 2026, AGC Biologics’ manufacturing site in Seattle successfully obtained Good Manufacturing Practices (GMP) certification from Agência Nacional... Read more

Category: Uncategorized

Tags: #Local Dynamics

Pfizer shares dip following Phase 2 results for $10B obesity drug asset

04/02/2026 Published by vivi

On February 3, 2026, Pfizer released topline data from its Phase 2b VESPER-3 study for PF-08653944, the ultra-long-acting obesity injection... Read more

Category: Uncategorized

Tags: #Local Dynamics